Dr. Jukka Hakkola has been named the Finnish Pharmacology Society’s representative to the Pharmacological Reviews editorial board where he will serve as an associate editor. Dr. Hakkola is a professor of pharmacology and head of the Research
Unit of Biomedicine at the University of Oulu. His research interests are metabolic pharmacology, xenobiotic-sensing nuclear receptors (especially PXR), diabetes and metabolic syndrome, fatty liver disease (NAFLD), hepatic molecular biology, endocrine
disrupting chemicals, and cytochrome P450 enzymes. He has 72 peer-reviewed publications in international journals and has an h-index of 33.00. Dr. Hakkola was president of the Finnish Pharmacological Society from 2011 to 2013.
Editorial supervision of Pharmacological Reviews is shared jointly with the pharmacological societies of Britain, Denmark, Finland, Norway, and Sweden. As such, each of those societies has a representative on the journal’s editorial board.
Dr. Hakkola succeeds Dr. Markku Koulu as the Finnish society’s representative. Dr. Koulu served the journal from 2007 until now.